This Article Full Text Full Text (PDF) All Versions of this Article: 35/8/1790    most recent 01.STR.0000132570.24618.78v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cantu, C. Articles by Barinagarrementeria, F. Search for Related Content PubMed PubMed Citation Articles by Cantu, C. Articles by Barinagarrementeria, F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB CYANOCOBALAMIN FOLIC ACID Related Collections Clinical genetics Thrombophilia Thrombosis risk factors Cerebral Venous Thrombosis

(Stroke. 2004;35:1790.)
© 2004 American Heart Association, Inc.

Original Contributions

Hyperhomocysteinemia, Low Folate and Vitamin B₁₂ Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis

Carlos Cantu, MD, MSc; Elisa Alonso, MD; Aurelio Jara, BSc; Leticia Martínez, BSc; Camilo Ríos, Ch, PhD; María de los Angeles Fernández, BSc; Irma Garcia, BSc Fernando Barinagarrementeria, MD

From the Stroke Clinic (C.C., F.B.) and the Departments of Genetics (E.A., A.J., L.M.), Neurochemistry (C.R.), and Radioimmunoassay (M.d.l.A.F., I.G.), Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez," Mexico. C.C. is now appointed at the Stroke Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City. F.B. has moved to Hospital Angeles, Querétaro, Mexico.

Correspondence to Dr Carlos Cantú, Stroke Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Col. Sección XVI, Tlalpan, México City, D.F. 14080, Mexico. E-mail carloscantu_brito{at}hotmail.com

Background and Purpose— Elevated plasma levels of homocysteine are associated with an increased risk of deep-vein thrombosis. Through a case–control study, we examined the potential association among homocysteine, folate and vitamin B₁₂ levels, and the common C677T mutation in the methylene tetrahydrofolate reductase (MTHFR) gene in patients with cerebral venous thrombosis (CVT).

Methods— Forty-five patients with CVT and 90 control subjects were studied. Plasma levels of homocysteine (fasting and after methionine load), folate, and vitamin B₁₂ were measured. Genotyping of the MTHFR gene was also performed. The estimated risk of CVT associated with hyperhomocysteinemia, low vitamin levels, and MTHFR mutation were expressed as odds ratio (OR) and its 95% CI (crude and after adjusting by other independent variables).

Results— The adjusted OR for CVT associated with high (>90th percentile) fasting levels of homocysteine was 4.6 (1.6 to 12.8). The association between low plasma folate values (<10th percentile) and presence of CVT was 3.5 (1.2 to 10.0) after adjustment for confounding factors. There was a higher frequency of MTHFR mutation in patients with CVT (22% versus 10%), but it was not statistically significant (P=0.098). Patients with MTHFR mutation and low folate levels presented the highest homocysteine levels.

Conclusions— High plasma concentrations of homocysteine and low plasma folate levels were associated with an increased risk of CVT in this population in which low socioeconomic conditions and deficient nutritional status may contribute to its relatively high incidence.

Key Words: cerebral thrombosis • sinus thrombosis • risk factors • coagulation • homocysteine

This article has been cited by other articles:

				V. Ducros, C. Barro, J. Yver, G. Pernod, B. Polack, P. Carpentier, M.-D. Desruet, and J.-L. Bosson Should Plasma Homocysteine Be Used as a Biomarker of Venous Thromboembolism? A Case--Control Study Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 517 - 522. [Abstract] [PDF]

				E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young Stroke, September 1, 2008; 39(9): 2644 - 2691. [Abstract] [Full Text] [PDF]

				C. L. Wong MD, H. G.C. Van Spall MD, K. A. Hassan MB, J. Coret-Simon MD, D. J. Sahlas MD, and S. L. Shumak MD A young man with deep vein thrombosis, hyperhomocysteinemia and cobalamin deficiency Can. Med. Assoc. J., January 29, 2008; 178(3): 279 - 281. [Full Text] [PDF]

				F. Dentali, M. Crowther, and W. Ageno Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis Blood, April 1, 2006; 107(7): 2766 - 2773. [Abstract] [Full Text] [PDF]

				J. Stam Thrombosis of the Cerebral Veins and Sinuses N. Engl. J. Med., April 28, 2005; 352(17): 1791 - 1798. [Full Text] [PDF]